
NVS · 医疗保健
Novartis AG
2026 Q2:3 位巨人持有,综合权重 0.02%,共识排名第 173;本季 0 位买入、1 位卖出。季末价 $156.72(2026-06-30)。
持有人数
3
上季 3 位
综合权重
0.02%
共识排名第 173
季末价
$156.72
2026-06-30
巨人的平均成本估
$74.36
季末价比这个平均高 111%(每位巨人的成本各算一次)
3 位巨人持有
依占投资组合比重排序;点名字看那位巨人的持股历程。
怎么看?
估计平均成本:每次增持的股数 ×(季初价+季末价)÷ 2 的加权平均;1999 年第一季(或这位巨人最早的电子申报)之前就持有的,从那个季度的季末价起算。13F 看不到实际成交价。
| 巨人 | ?占投资组合 | ?估计平均成本 | ?相对成本 | 本季动向 |
|---|---|---|---|---|
| Tweedy, Browne | 0.8% | $51.12起算点 | +207% | 不变 |
| Thomas Kahn | 0.3% | $83.18起算点 | +88% | 减持 |
| Sarah Ketterer | <0.1% | $88.78起算点 | +77% | 不变 |
成本地图:3 位中有 3 位的估计成本低于季末价
每一行是一位巨人:圆点是估计平均成本(越大=占投资组合越重),金色直线是最新季末价。
成本低于季末价(账面浮盈)成本高于季末价(账面浮亏)季末价
季末价走势(已按拆股调整)
1999 Q3 起,也就是巨人第一次持有的那个季度;悬停看当季持有人数与买卖人数。
怎么看?
价格是 13F 申报的季末市值 ÷ 股数,约等于季末收盘价,不是即时价格;拆股前的价格已换算成今天的股数。
越来越多还是越来越少巨人持有
持有人数
每季度买家与卖家(近 20 个季度)
买入卖出
综合权重(悬停看排名)
持股历程
点开一位巨人:他从什么时候开始持有、哪几季买卖、估计成本怎么变化。表格只列有买卖的季度和最新一季。
怎么看?
图中的价格与成本都换算成今天的股数(已按拆股调整);表格里是当季实际的数字。估计成交价=(季初价+季末价)÷ 2,只代表大致价位。
Tweedy, Browne 0.8%·1999 Q1 起
季末价累计估计成本估计成交价(买/卖)
| 季度 | 动作 | 股数变动(万股) | 占投资组合 | 累计估计成本 |
|---|---|---|---|---|
| 2026 Q2 | 不变 | — | 0.8% | $51.12 |
| 2026 Q1 | 减持 | −<1 | 0.9% | $51.12 |
| 2025 Q4 | 减持 | −<1 | 0.8% | $51.12 |
| 2025 Q3 | 减持 | −<1 | 0.8% | $51.12 |
| 2025 Q2 | 减持 | −<1 | 0.9% | $51.12 |
| 2025 Q1 | 减持 | −<1 | 0.8% | $51.12 |
| 2024 Q4 | 减持 | −<1 | 0.5% | $51.12 |
| 2024 Q3 | 减持 | −<1 | 0.5% | $51.12 |
| 2024 Q2 | 减持 | −<1 | 0.4% | $51.12 |
| 2024 Q1 | 减持 | −<1 | 0.4% | $51.12 |
| 2023 Q4 | 减持 | −<1 | 0.4% | $51.12 |
| 2023 Q3 | 减持 | −<1 | 0.5% | $51.12 |
| 2023 Q2 | 减持 | −<1 | 0.5% | $51.12 |
| 2023 Q1 | 减持 | −<1 | 0.5% | $51.12 |
| 2022 Q4 | 减持 | −<1 | 0.5% | $51.12 |
| 2022 Q3 | 增持 | +<1 | 0.3% | $51.12 |
| 2022 Q2 | 减持 | −<1 | 0.3% | $50.44 |
| 2022 Q1 | 减持 | −<1 | 0.3% | $50.44 |
| 2021 Q4 | 减持 | −1 | 0.3% | $50.44 |
| 2021 Q3 | 减持 | −<1 | 0.3% | $50.44 |
| 2021 Q2 | 减持 | −1 | 0.3% | $50.44 |
| 2021 Q1 | 减持 | −<1 | 0.3% | $50.44 |
| 2020 Q4 | 减持 | −1 | 0.4% | $50.44 |
| 2020 Q3 | 减持 | −<1 | 0.5% | $50.44 |
| 2020 Q2 | 减持 | −1 | 0.5% | $50.44 |
| 2020 Q1 | 减持 | −<1 | 0.6% | $50.44 |
| 2019 Q4 | 减持 | −<1 | 0.5% | $50.44 |
| 2019 Q3 | 减持 | −<1 | 0.5% | $50.44 |
| 2019 Q2 | 减持 | −<1 | 0.5% | $50.44 |
| 2019 Q1 | 减持 | −1 | 0.5% | $50.44 |
| 2018 Q4 | 减持 | −1 | 0.5% | $50.44 |
| 2018 Q3 | 减持 | −<1 | 0.5% | $50.44 |
| 2018 Q2 | 减持 | −<1 | 0.4% | $50.44 |
| 2018 Q1 | 减持 | −<1 | 0.5% | $50.44 |
| 2017 Q4 | 减持 | −1 | 0.4% | $50.44 |
| 2017 Q2 | 减持 | −1 | 0.5% | $50.44 |
| 2017 Q1 | 减持 | −1 | 0.4% | $50.44 |
| 2016 Q4 | 减持 | −<1 | 0.5% | $50.44 |
| 2016 Q3 | 减持 | −1 | 0.5% | $50.44 |
| 2016 Q2 | 减持 | −<1 | 0.5% | $50.44 |
| 2016 Q1 | 减持 | −<1 | 0.5% | $50.44 |
| 2015 Q4 | 减持 | −1 | 0.6% | $50.44 |
| 2015 Q3 | 减持 | −1 | 0.7% | $50.44 |
| 2015 Q2 | 减持 | −1 | 0.7% | $50.44 |
| 2015 Q1 | 减持 | −1 | 0.7% | $50.44 |
| 2014 Q4 | 减持 | −2 | 0.6% | $50.44 |
| 2014 Q3 | 减持 | −<1 | 0.6% | $50.44 |
| 2014 Q2 | 减持 | −<1 | 0.6% | $50.44 |
| 2013 Q4 | 减持 | −<1 | 0.5% | $50.44 |
| 2013 Q2 | 减持 | −1 | 0.5% | $50.44 |
| 2012 Q3 | 减持 | −2 | 0.7% | $50.44 |
| 2012 Q1 | 减持 | −2 | 0.6% | $50.44 |
| 2011 Q4 | 减持 | −1 | 0.7% | $50.44 |
| 2011 Q3 | 减持 | −<1 | 0.8% | $50.44 |
| 2011 Q2 | 减持 | −1 | 0.7% | $50.44 |
| 2011 Q1 | 减持 | −1 | 0.7% | $50.44 |
| 2010 Q4 | 减持 | −1 | 0.8% | $50.44 |
| 2010 Q3 | 减持 | −1 | 0.8% | $50.44 |
| 2010 Q2 | 减持 | −2 | 0.8% | $50.44 |
| 2010 Q1 | 减持 | −3 | 0.9% | $50.44 |
| 2009 Q4 | 增持 | +3 | 0.9% | $50.44 |
| 2009 Q3 | 增持 | +25 | 1.2% | $50.31 |
| 2009 Q2 | 增持 | +<1 | 0.4% | $58.59 |
| 2009 Q1 | 减持 | −1 | 0.4% | $59.12 |
| 2008 Q4 | 减持 | −<1 | 0.5% | $59.12 |
| 2008 Q3 | 减持 | −1 | 0.5% | $59.12 |
| 2008 Q2 | 减持 | −<1 | 0.5% | $59.12 |
| 2008 Q1 | 减持 | −<1 | 0.4% | $59.12 |
| 2007 Q4 | 减持 | −<1 | 0.4% | $59.12 |
| 2007 Q3 | 减持 | −<1 | 0.4% | $59.12 |
| 2007 Q2 | 减持 | −1 | 0.3% | $59.12 |
| 2007 Q1 | 减持 | −1 | 0.3% | $59.12 |
| 2006 Q4 | 减持 | −6 | 0.3% | $59.12 |
| 2006 Q3 | 增持 | +<1 | 0.5% | $59.12 |
| 2006 Q2 | 减持 | −<1 | 0.5% | $59.17 |
| 2006 Q1 | 减持 | −5 | 0.5% | $59.17 |
| 2005 Q4 | 减持 | −4 | 0.6% | $59.17 |
| 2005 Q3 | 减持 | −1 | 0.6% | $59.17 |
| 2005 Q2 | 减持 | −1 | 0.6% | $59.17 |
| 2005 Q1 | 减持 | −1 | 0.6% | $59.17 |
| 2004 Q4 | 减持 | −1 | 0.6% | $59.17 |
| 2004 Q3 | 减持 | −1 | 0.6% | $59.17 |
| 2004 Q2 | 减持 | −1 | 0.6% | $59.17 |
| 2004 Q1 | 增持 | +<1 | 0.6% | $59.17 |
| 2003 Q4 | 减持 | −3 | 0.6% | $59.32 |
| 2003 Q3 | 增持 | +1 | 0.6% | $59.32 |
| 2003 Q2 | 增持 | +4 | 0.6% | $59.60 |
| 2003 Q1 | 减持 | −1 | 0.5% | $61.55 |
| 2002 Q4 | 增持 | +1 | 0.5% | $61.55 |
| 2002 Q3 | 减持 | −1 | 0.5% | $61.99 |
| 2002 Q1 | 增持 | +1 | 0.4% | $61.99 |
| 2001 Q4 | 增持 | +<1 | 0.4% | $62.71 |
| 2001 Q3 | 增持 | +1 | 0.4% | $62.99 |
| 2001 Q2 | 增持 | +1 | 0.3% | $63.71 |
| 2001 Q1 | 增持 | +1 | 0.3% | $64.80 |
| 2000 Q2 | 增持 | +18 | 0.4% | $65.75 |
| 2000 Q1 | 增持 | +1 | 0.3% | $79.45 |
| 1999 Q4 | 减持 | −1 | 0.3% | $80.27 |
Thomas Kahn 0.3%·1999 Q1 起
季末价累计估计成本估计成交价(买/卖)
| 季度 | 动作 | 股数变动(万股) | 占投资组合 | 累计估计成本 |
|---|---|---|---|---|
| 2026 Q2 | 减持 | −<1 | 0.3% | $83.18 |
| 2026 Q1 | 减持 | −<1 | 0.4% | $83.18 |
| 2025 Q4 | 减持 | −<1 | 0.3% | $83.18 |
| 2025 Q3 | 减持 | −<1 | 0.3% | $83.18 |
| 2025 Q2 | 减持 | −<1 | 0.4% | $83.18 |
| 2025 Q1 | 增持 | +<1 | 0.5% | $83.18 |
| 2024 Q4 | 增持 | +<1 | 0.4% | $82.45 |
| 2024 Q2 | 增持 | +<1 | 0.3% | $77.59 |
| 2024 Q1 | 减持 | −<1 | 0.2% | $74.22 |
| 2023 Q4 | 减持 | −<1 | 0.3% | $74.22 |
| 2022 Q4 | 减持 | −<1 | 0.3% | $74.22 |
| 2022 Q2 | 增持 | +<1 | 0.3% | $74.22 |
| 2021 Q4 | 增持 | +<1 | 0.3% | $73.85 |
| 2021 Q1 | 减持 | −<1 | 0.3% | $72.80 |
| 2020 Q4 | 减持 | −<1 | 0.4% | $72.80 |
| 2020 Q2 | 减持 | −<1 | 0.3% | $72.80 |
| 2020 Q1 | 减持 | −<1 | 0.3% | $72.80 |
| 2019 Q2 | 增持 | +<1 | 0.3% | $72.80 |
| 2018 Q4 | 减持 | −<1 | 0.4% | $70.01 |
| 2018 Q2 | 增持 | +<1 | 0.3% | $70.01 |
| 2018 Q1 | 减持 | −<1 | 0.3% | $69.57 |
| 2017 Q4 | 增持 | +<1 | 0.4% | $69.57 |
| 2017 Q2 | 减持 | −<1 | 0.3% | $69.29 |
| 2017 Q1 | 增持 | +<1 | 0.4% | $69.29 |
| 2016 Q4 | 减持 | −<1 | 0.3% | $69.16 |
| 2015 Q4 | 减持 | −<1 | 0.4% | $69.16 |
| 2015 Q3 | 增持 | +<1 | 0.5% | $69.16 |
| 2015 Q2 | 减持 | −<1 | 0.5% | $68.79 |
| 2014 Q4 | 增持 | +<1 | 0.5% | $68.79 |
| 2014 Q3 | 增持 | +<1 | 0.5% | $68.31 |
| 2014 Q2 | 减持 | −<1 | 0.3% | $64.66 |
| 2014 Q1 | 增持 | +<1 | 0.3% | $64.66 |
| 2013 Q4 | 减持 | −<1 | 0.4% | $64.20 |
| 2013 Q3 | 减持 | −<1 | 0.3% | $64.20 |
| 2013 Q2 | 减持 | −<1 | 0.3% | $64.20 |
| 2013 Q1 | 减持 | −1 | 0.4% | $64.20 |
| 2012 Q4 | 增持 | +<1 | 0.5% | $64.20 |
| 2012 Q3 | 减持 | −<1 | 0.4% | $64.40 |
| 2012 Q2 | 减持 | −<1 | 0.4% | $64.40 |
| 2012 Q1 | 减持 | −1 | 0.4% | $64.40 |
| 2011 Q4 | 减持 | −<1 | 0.5% | $64.40 |
| 2011 Q3 | 减持 | −<1 | 0.6% | $64.40 |
| 2011 Q2 | 增持 | +<1 | 0.5% | $64.40 |
| 2011 Q1 | 减持 | −4 | 0.4% | $64.66 |
| 2010 Q4 | 减持 | −1 | 1.0% | $64.66 |
| 2010 Q3 | 减持 | −<1 | 1.2% | $64.66 |
| 2010 Q2 | 减持 | −5 | 1.1% | $64.66 |
| 2010 Q1 | 减持 | −1 | 1.7% | $64.66 |
| 2009 Q4 | 减持 | −<1 | 2.1% | $64.66 |
| 2009 Q3 | 减持 | −<1 | 1.9% | $64.66 |
| 2009 Q2 | 增持 | +<1 | 1.8% | $64.66 |
| 2009 Q1 | 减持 | −1 | 1.8% | $65.04 |
| 2007 Q1 | 减持 | −<1 | 1.5% | $65.36 |
| 2006 Q4 | 减持 | −1 | 1.6% | $65.36 |
| 2006 Q1 | 减持 | −<1 | 1.7% | $65.36 |
| 2005 Q4 | 减持 | −1 | 1.7% | $65.36 |
| 2005 Q3 | 增持 | +<1 | 1.6% | $65.36 |
| 2005 Q2 | 增持 | +1 | 1.5% | $65.59 |
| 2004 Q2 | 减持 | −<1 | 1.5% | $66.60 |
| 2004 Q1 | 减持 | −1 | 1.4% | $66.60 |
| 2001 Q1 | 增持 | +<1 | 3.0% | $67.19 |
| 2000 Q3 | 减持 | −4 | 3.0% | $67.78 |
| 2000 Q2 | 增持 | +11 | 3.9% | $67.78 |
| 1999 Q4 | 减持 | −<1 | 3.1% | $81.11 |
| 1999 Q3 | 减持 | −3 | 3.1% | $81.11 |
Sarah Ketterer <0.1%·2005 Q4 起
季末价累计估计成本估计成交价(买/卖)
| 季度 | 动作 | 股数变动(万股) | 占投资组合 | 累计估计成本 |
|---|---|---|---|---|
| 2026 Q2 | 增持 | +<1 | <0.1% | $88.78 |
| 2026 Q1 | 减持 | −<1 | <0.1% | $88.16 |
| 2025 Q4 | 减持 | −<1 | <0.1% | $88.16 |
| 2025 Q3 | 减持 | −<1 | <0.1% | $88.16 |
| 2025 Q2 | 减持 | −<1 | <0.1% | $88.16 |
| 2025 Q1 | 减持 | −<1 | <0.1% | $88.16 |
| 2024 Q4 | 减持 | −<1 | <0.1% | $88.16 |
| 2024 Q3 | 减持 | −19 | <0.1% | $88.16 |
| 2024 Q2 | 减持 | −4 | 0.6% | $88.16 |
| 2024 Q1 | 增持 | +3 | 0.6% | $88.16 |
| 2023 Q4 | 增持 | +2 | 0.5% | $86.61 |
| 2023 Q3 | 减持 | −4 | 0.5% | $84.86 |
| 2023 Q2 | 减持 | −2 | 0.6% | $84.86 |
| 2023 Q1 | 增持 | +2 | 0.5% | $84.86 |
| 2022 Q4 | 减持 | −5 | 0.6% | $84.20 |
| 2022 Q3 | 减持 | −4 | 0.6% | $84.20 |
| 2022 Q2 | 减持 | −8 | 0.7% | $84.20 |
| 2022 Q1 | 增持 | +1 | 0.8% | $84.20 |
| 2021 Q4 | 减持 | −2 | 0.7% | $84.11 |
| 2021 Q3 | 减持 | −3 | 0.7% | $84.11 |
| 2021 Q2 | 增持 | +3 | 0.8% | $84.11 |
| 2021 Q1 | 增持 | +9 | 0.7% | $83.79 |
| 2020 Q4 | 减持 | −1 | 0.5% | $81.94 |
| 2020 Q3 | 减持 | −1 | 0.5% | $81.94 |
| 2020 Q1 | 增持 | +3 | 0.4% | $81.94 |
| 2019 Q4 | 增持 | +4 | 0.3% | $81.20 |
| 2019 Q3 | 减持 | −2 | 0.3% | $79.86 |
| 2019 Q2 | 减持 | −1 | 0.3% | $79.86 |
| 2019 Q1 | 减持 | −1 | 0.3% | $79.86 |
| 2018 Q4 | 减持 | −16 | 0.3% | $79.86 |
| 2018 Q3 | 减持 | −1 | 0.4% | $79.86 |
| 2018 Q2 | 增持 | +5 | 0.4% | $79.86 |
| 2018 Q1 | 增持 | +7 | 0.4% | $80.07 |
| 2017 Q4 | 增持 | +3 | 0.3% | $79.56 |
| 2017 Q3 | 减持 | −6 | 0.3% | $79.09 |
| 2017 Q2 | 增持 | +3 | 0.4% | $79.09 |
| 2017 Q1 | 增持 | +2 | 0.3% | $79.11 |
| 2016 Q4 | 减持 | −<1 | 0.4% | $79.46 |
| 2016 Q3 | 增持 | +<1 | 0.5% | $79.46 |
| 2016 Q2 | 增持 | +<1 | 0.6% | $79.45 |
| 2016 Q1 | 增持 | +3 | 0.6% | $79.47 |
| 2015 Q4 | 增持 | +2 | 0.5% | $79.50 |
| 2015 Q2 | 增持 | +1 | 0.6% | $77.02 |
| 2015 Q1 | 减持 | −11 | 0.6% | $75.67 |
| 2014 Q4 | 增持 | +<1 | 0.9% | $75.67 |
| 2014 Q3 | 增持 | +1 | 1.1% | $75.56 |
| 2014 Q2 | 减持 | −1 | 1.1% | $74.86 |
| 2014 Q1 | 增持 | +5 | 1.3% | $74.86 |
| 2013 Q4 | 增持 | +21 | 1.3% | $73.59 |
| 2013 Q3 | 增持 | +1 | 0.4% | $59.11 |

